AVP application to the inner ear tissues could activate V2-R and AC with cAMP elevation and AQP2 translocation (6, 7), resulting in the inner ear endolymphatic hydrops (8, 9). The gene discussed is AVPR2; the disease is endolymphatic hydrops.